- Home
- QNRX vs DLXY Comparison
QNRX vs DLXY Comparison
Compare QNRX & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNRX | DLXY |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 9.3M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | QNRX | DLXY |
|---|---|---|
| Price | $4.90 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.1K | ★ 134.4K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.80 | $0.45 |
| 52 Week High | $41.80 | $7.00 |
Technical Indicators
Market Signals| Indicator | QNRX | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 29.59 | 40.39 |
| Support Level | N/A | $0.46 |
| Resistance Level | $6.84 | $0.97 |
| Average True Range (ATR) | 0.43 | 0.06 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 8.57 | 13.14 |
Price Performance
Historical ComparisonAbout QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About DLXY Delixy Holdings Limited Ordinary Shares
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.